PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Sep 2006 07:30

London Asia Chinese Private Equity06 September 2006 6 September 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Investee Companies Trading On PLUS LACPEF, the China focused investment fund, is pleased to announce that two moreof its investee companies are to begin trading on the UK's PLUS Markets StockMarket. China New Energy Ltd ("CNE") is expected to begin trading today at 525p a share,giving it a market capitalisation of £35 million. Its core business is thesupply of turnkey technology solutions for the production of ethanol, ediblealcohol and acetic acid from a range of bio-resources, including corn,sugarcane, cassava and other bio-resources. As part of the listing process, theFund has invested a further £0.35 million, bringing its total investment in CNEto date to £2.2 million for a 25% stake. CNE is seeking a listing to enable itto tap into the international market for its product, with sales currentlyfocused on the Chinese market. China Biofoods Ltd ("Biofoods") is expected to begin trading on Thursday 7September at 175p a share, giving it a market capitalisation of £12.5 million.The Fund took a 31% stake in June at a cost of £2.1 million. Biofoodsspecialises in the production of highly purified herb extract products, whichare then used to produce traditional Chinese medicine, and as ingredients infunctional foods. China Biofoods reported revenues of £2.9m with profit aftertax of £1.2m for the year ended 31 December 2005. It is listing on PLUS as away of tapping into the international market for its products. Simon Littlewood, Executive Director of LACPEF, commented: "These listings onPLUS follow the successful listing of our investee company Dalian BusinessInstitute in May, with Dalian currently trading at a market capitalisation ofover £18 million, valuing the Fund's stake at £3.6 million against an investmentcost of £2.0 million. The listings demonstrate the value in our investmentportfolio. CNE is listing as it will need considerable amounts of capital goingforward as it seeks to take advantage of its leading position in the ethanolsector in China, where as a result of recent changes in legislation there hasbeen a rapid expansion in the size of the market, as well as taking advantage ofopportunities outside China, with ethanol being looked at worldwide as apotential alternative to highly priced oil. Biofoods is expanding its productrange, and looking to tie up with international partners to sell its productsoverseas." For further information please visit www.londonasiafunds.com or contact: John West/Matt Ridsdale Simon Littlewood Hugh FieldTavistock Communications London Asia Capital plc Collins Stewart LimitedTel: 020 7920 3150 Tel 020 7355 7928 Tel: 020 7523 8000 About China New Energy CNE has established itself as the leading brand in China, with an estimated 60%share of the market for ethanol production equipment in China. The Company'ssuccessful track record is key to growing the business and its technology hasbeen used in over 30 projects. CNE is supported by strong drivers with thedemand for ethanol, a fuel seen as an alternative to oil, growing rapidly andsupported by a recent change in legislation in China requiring 10% of allvehicle oil consumption to be biofuel in 11 of China's Provinces. Similarlegislation is coming into force in many countries, such as the US and EU,creating a potential market for CNE to export its products going forward. For additional information, visit the Company's web site atwww.chinanewenergygroup.com About China Biofoods Biofoods is based in Xuchang, Henan Province, the centre for farming traditionalChinese medical herbs. It specialises in the production of highly purified herbextract products, which are then used to produce traditional Chinese medicine,and as ingredients in functional foods. The market for "Functional Foods" is expanding rapidly worldwide, especially inChina. "Functional Foods" are foods or dietary components that may provide ahealth benefit beyond their basic nutritional value. Such products are aimed ata wide variety of markets, from those with poor diets and limited resourcesseeking additional nutritional content in their diet, to those whose lifestylesand levels of stress require them to eat more healthy food, to the aged who areseeking traditional cures to age related ailments. Biofoods' core products are highly purified linolenic acids, Reshi mushroomspore oil, and deodorized garlic oil. Linolenic acid, also known as Vitamin F,is an essential fatty acid which is not produced by the body, and has been usedto improve hair and skin, reduce blood pressure, help prevent arthritis, lowercholesterol and triglycerides, and reduce the risk of blood clots. Reshimushroom spore oil is broadly used in the health food industry as a supplementand intermediate ingredient. For additional information, please visit the company's web pagewww.chinabiofoods.com.cn This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jun 20127:00 amRNSFinal Results
8th Jun 201212:28 pmRNSDirector/PDMR Shareholding
7th Jun 20123:35 pmRNSHolding(s) in Company
6th Jun 201211:57 amRNSHolding(s) in Company
31st May 20129:34 amRNSHolding(s) in Company
28th May 201211:57 amRNSResult of EGM
23rd May 20128:40 amRNSHolding(s) in Company
14th May 20124:53 pmRNSHolding(s) in Company
4th May 20127:00 amRNSProposed Subscription and Return of Capital
29th Nov 20117:00 amRNSHalf Yearly Results
23rd Sep 20119:51 amRNSAGM Statement
30th Aug 20111:38 pmRNSChange of Registered Office
4th Aug 20117:00 amRNSFinal Results
28th Jul 20119:30 amRNSIn Specie Distribution
8th Jun 20113:46 pmRNSReturn of capital
24th Mar 201112:08 pmRNSUpdate re China CDM
8th Feb 20112:31 pmRNSFinal date for Warrant Exercise
20th Jan 201111:10 amRNSHolding(s) in Company
18th Jan 20119:44 amRNSHolding(s) in Company
17th Jan 20115:36 pmRNSHolding(s) in Company
17th Jan 20115:35 pmRNSHolding(s) in Company
17th Jan 201111:02 amRNSDirector/PDMR Shareholding
13th Jan 20113:46 pmRNSReturn of Capital and disposal
7th Dec 20108:19 amRNSHalf Yearly Report
16th Nov 201012:30 pmRNSInvestment Update
5th Nov 20101:43 pmRNSHolding(s) in Company
8th Oct 20104:19 pmRNSHolding(s) in Company
14th Sep 20109:32 amRNSResult of AGM
17th Aug 20107:00 amRNSAnnual Financial Report
10th Aug 20107:00 amRNSFinal Results
11th Jun 20105:01 pmRNSHolding(s) in Company
18th Mar 201011:16 amRNSHolding(s) in Company
26th Feb 20103:57 pmRNSHolding(s) in Company
8th Dec 200910:18 amRNSHalf Yearly Report
6th Nov 20098:39 amRNSChange of Adviser
5th Nov 20098:46 amRNSHolding(s) in Company
22nd Oct 20091:48 pmRNSInvesting Policy
20th Oct 20099:52 amRNSDirectorate Change
29th Sep 20092:12 pmRNSTermination of Asset Divestment Support Agreement
16th Sep 200911:45 amRNSReturn of Capital
16th Sep 200911:33 amRNSResult of AGM
28th Aug 20099:12 amRNSSale of China New Energy
7th Aug 20099:03 amRNSHolding(s) in Company
3rd Aug 20094:58 pmRNSHolding(s) in Company
14th Jul 20093:52 pmRNSAnnual Report and Financial Statements
9th Jul 20097:00 amRNSFinal Results
6th Jul 200911:44 amRNSResult of EGM
29th Jun 20094:24 pmRNSHolding(s) in Company
10th Jun 20097:00 amRNSReturn of Capital
3rd Jun 200912:48 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.